Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 79

1.

Oxidation of dCTP contributes to antibiotic lethality in stationary-phase mycobacteria.

Fan XY, Tang BK, Xu YY, Han AX, Shi KX, Wu YK, Ye Y, Wei ML, Niu C, Wong KW, Zhao GP, Lyu LD.

Proc Natl Acad Sci U S A. 2018 Feb 27;115(9):2210-2215. doi: 10.1073/pnas.1719627115. Epub 2018 Jan 30.

2.

Cloning identification and functional analysis of human IL-17A promoter.

Hu MJ, Wu SW, Wei ML, Xi J, Wang L, Han YZ, Tang BK, Fang Q, Xu L.

Asian Pac J Trop Med. 2016 Aug;9(8):777-80. doi: 10.1016/j.apjtm.2016.06.007. Epub 2016 Jun 29.

3.

[Sequence homology analysis on lactate dehydrogenase (LDH) of Plasmodium vivax Anhui isolates].

Hu MJ, Fang Q, Wu SW, Tang BK, Zhang J, Jiao YM, Xia H, Shen JL.

Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi. 2013 Apr;31(2):148-50. Chinese.

PMID:
24809200
4.

Mycobacterial MazG safeguards genetic stability via housecleaning of 5-OH-dCTP.

Lyu LD, Tang BK, Fan XY, Ma H, Zhao GP.

PLoS Pathog. 2013;9(12):e1003814. doi: 10.1371/journal.ppat.1003814. Epub 2013 Dec 5.

5.

Relaxation strategies and enhancement of hypnotic susceptibility: EEG neurofeedback, progressive muscle relaxation and self-hypnosis.

Batty MJ, Bonnington S, Tang BK, Hawken MB, Gruzelier JH.

Brain Res Bull. 2006 Dec 11;71(1-3):83-90. Epub 2006 Sep 1.

PMID:
17113932
6.

[Effects of veratryl alcohol and tween 80 on ligninase production and its roles in decolorization of azo dyes by white-rot basidiomycete PM2].

Jia R, Tang BK, Zhang XB, He YM.

Sheng Wu Gong Cheng Xue Bao. 2004 Mar;20(2):302-5. Chinese.

PMID:
15969128
7.

A simple test for acetylator phenotype using caffeine. 1984.

Grant DM, Tang BK, Kalow W.

Br J Clin Pharmacol. 2004 Dec;58(7):S788-93; discussion S794-5. No abstract available.

8.

Cytochrome P450 1A2 (CYP1A2) activity and risk factors for breast cancer: a cross-sectional study.

Hong CC, Tang BK, Hammond GL, Tritchler D, Yaffe M, Boyd NF.

Breast Cancer Res. 2004;6(4):R352-65. Epub 2004 May 7.

9.

Cytochrome P450 1A2 (CYP1A2) activity, mammographic density, and oxidative stress: a cross-sectional study.

Hong CC, Tang BK, Rao V, Agarwal S, Martin L, Tritchler D, Yaffe M, Boyd NF.

Breast Cancer Res. 2004;6(4):R338-51. Epub 2004 May 7.

10.

Mulitvariate cluster analysis of a human hepatic cytochrome P450 database.

Sy SK, Johnston JA, Class CF, Roberts EA, Kalow W, Tang BK.

Eur J Clin Pharmacol. 2002 Nov;58(8):559-62. No abstract available.

PMID:
12536990
11.

Modeling of human hepatic CYP3A4 enzyme kinetics, protein, and mRNA indicates deviation from log-normal distribution in CYP3A4 gene expression.

Sy SK, Ciaccia A, Li W, Roberts EA, Okey A, Kalow W, Tang BK.

Eur J Clin Pharmacol. 2002 Aug;58(5):357-65. Epub 2002 Jul 13.

PMID:
12185560
12.
13.

CYP1A2 activity as measured by a caffeine test predicts clozapine and active metabolite steady-state concentrationin patients with schizophrenia.

Ozdemir V, Kalow W, Posner P, Collins EJ, Kennedy JL, Tang BK, Albers LJ, Reist C, Roy R, Walkes W, Afra P.

J Clin Psychopharmacol. 2001 Aug;21(4):398-407.

PMID:
11476124
14.

Evaluation of the genetic component of variability in CYP3A4 activity: a repeated drug administration method.

Ozdemir V, Kalow W, Tang BK, Paterson AD, Walker SE, Endrenyi L, Kashuba AD.

Pharmacogenetics. 2000 Jul;10(5):373-88.

PMID:
10898107
15.

The science of pharmacological variability: an essay.

Kalow W, Ozdemir V, Tang BK, Tothfalusi L, Endrenyi L.

Clin Pharmacol Ther. 1999 Nov;66(5):445-7. No abstract available.

PMID:
10579470
16.

Trimethadione metabolism by human liver cytochrome P450: evidence for the involvement of CYP2E1.

Kurata N, Nishimura Y, Iwase M, Fischer NE, Tang BK, Inaba T, Yasuhara H.

Xenobiotica. 1998 Nov;28(11):1041-7.

PMID:
9879636
18.

Caffeine based measures of CYP1A2 activity correlate with oral clearance of tacrine in patients with Alzheimer's disease.

Fontana RJ, deVries TM, Woolf TF, Knapp MJ, Brown AS, Kaminsky LS, Tang BK, Foster NL, Brown RR, Watkins PB.

Br J Clin Pharmacol. 1998 Sep;46(3):221-8.

19.

Hypothesis: comparisons of inter- and intra-individual variations can substitute for twin studies in drug research.

Kalow W, Tang BK, Endrenyi L.

Pharmacogenetics. 1998 Aug;8(4):283-9. Review.

PMID:
9731714
20.

Distinction of CYP1A1 and CYP1A2 activity by selective inhibition using fluvoxamine and isosafrole.

Pastrakuljic A, Tang BK, Roberts EA, Kalow W.

Biochem Pharmacol. 1997 Feb 21;53(4):531-8.

PMID:
9105404
21.
22.

Role of CYP1A2 in caffeine pharmacokinetics and metabolism: studies using mice deficient in CYP1A2.

Buters JT, Tang BK, Pineau T, Gelboin HV, Kimura S, Gonzalez FJ.

Pharmacogenetics. 1996 Aug;6(4):291-6.

PMID:
8873215
24.

A sensitive method for determination of cytochrome P4502D6 activity in vitro using bupranolol as substrate.

Appanna G, Tang BK, Mller R, Kalow W.

Drug Metab Dispos. 1996 Mar;24(3):303-6.

PMID:
8820420
25.

Assays for CYP1A2 by testing in vivo metabolism of caffeine in humans.

Tang BK, Kalow W.

Methods Enzymol. 1996;272:124-31. No abstract available.

PMID:
8791769
26.

A urinary marker of alcohol intake.

Yu MC, Tang BK, Ross RK.

Cancer Epidemiol Biomarkers Prev. 1995 Dec;4(8):849-55.

27.

Interindividual variability in the glucuronidation of (S) oxazepam contrasted with that of (R) oxazepam.

Patel M, Tang BK, Grant DM, Kalow W.

Pharmacogenetics. 1995 Oct;5(5):287-97.

PMID:
8563769
28.

(S)oxazepam glucuronidation is inhibited by ketoprofen and other substrates of UGT2B7.

Patel M, Tang BK, Kalow W.

Pharmacogenetics. 1995 Feb;5(1):43-9.

PMID:
7773302
29.

Induction of P-450 in workers exposed to dioxin.

Halperin W, Kalow W, Sweeney MH, Tang BK, Fingerhut M, Timpkins B, Wille K.

Occup Environ Med. 1995 Feb;52(2):86-91.

30.

Individual Variability of Carbonyl Reductase Activity for Acetohexaminde in Human Erythorcytes.

Kishimoto M, Sano H, Chang F, Kawamori R, Kamada T, Tang BK, Inaba T.

Am J Ther. 1995 Jan;2(1):47-49.

PMID:
11850647
31.

Low CYP1A2 activity in rural Shona children of Zimbabwe.

Masimirembwa CM, Beke M, Hasler JA, Tang BK, Kalow W.

Clin Pharmacol Ther. 1995 Jan;57(1):25-31.

PMID:
7828378
32.

Variable activation of lovastatin by hydrolytic enzymes in human plasma and liver. 4.

Tang BK, Kalow W.

Eur J Clin Pharmacol. 1995;47(5):449-51.

PMID:
7720768
33.

Caffeine biotransformation in human hepatocyte lines derived from normal liver tissue.

Roberts EA, Furuya KN, Tang BK, Kalow W.

Biochem Biophys Res Commun. 1994 Jun 15;201(2):559-66.

PMID:
8002987
34.
35.

The use of caffeine for enzyme assays: a critical appraisal.

Kalow W, Tang BK.

Clin Pharmacol Ther. 1993 May;53(5):503-14. Review. No abstract available.

PMID:
8491061
36.

Utilizing urinary metabolite data in studying the variability of acetaminophen metabolism.

Patel M, Tang BK, Kalow W.

Pharmacogenetics. 1993 Feb;3(1):60. No abstract available.

PMID:
8485587
37.

Biotransformation of caffeine, paraxanthine, theobromine and theophylline by cDNA-expressed human CYP1A2 and CYP2E1.

Gu L, Gonzalez FJ, Kalow W, Tang BK.

Pharmacogenetics. 1992 Apr;2(2):73-7.

PMID:
1302044
38.

Variability of acetaminophen metabolism in Caucasians and Orientals.

Patel M, Tang BK, Kalow W.

Pharmacogenetics. 1992 Feb;2(1):38-45.

PMID:
1302042
39.

Use of caffeine metabolite ratios to explore CYP1A2 and xanthine oxidase activities.

Kalow W, Tang BK.

Clin Pharmacol Ther. 1991 Nov;50(5 Pt 1):508-19.

PMID:
1934864
40.

Urinary markers of chronic excessive ethanol consumption.

Tang BK.

Alcohol Clin Exp Res. 1991 Oct;15(5):881-5.

PMID:
1755523
41.

Caffeine as a metabolic probe: validation of its use for acetylator phenotyping.

Tang BK, Kadar D, Qian L, Iriah J, Yip J, Kalow W.

Clin Pharmacol Ther. 1991 Jun;49(6):648-57.

PMID:
2060254
42.
43.

Prominence of slow acetylator phenotype among patients with sulfonamide hypersensitivity reactions.

Rieder MJ, Shear NH, Kanee A, Tang BK, Spielberg SP.

Clin Pharmacol Ther. 1991 Jan;49(1):13-7.

PMID:
1988235
45.

Drug glucosidation.

Tang BK.

Pharmacol Ther. 1990;46(1):53-6. Review.

PMID:
2181491
46.

In vitro studies of human liver alcohol dehydrogenase variants using a variety of substrates.

Kassam JP, Tang BK, Kadar D, Kalow W.

Drug Metab Dispos. 1989 Sep-Oct;17(5):567-72.

PMID:
2573502
47.

Method to determine the enantiomers of ibuprofen from human urine by high-performance liquid chromatography.

Nicoll-Griffith DA, Inaba T, Tang BK, Kalow W.

J Chromatogr. 1988 Jun 24;428(1):103-12.

PMID:
3170663
49.

An alternative test for acetylator phenotyping with caffeine.

Tang BK, Kadar D, Kalow W.

Clin Pharmacol Ther. 1987 Nov;42(5):509-13.

PMID:
3677540
50.

Detection of ethanol in urine of abstaining alcoholics.

Tang BK.

Can J Physiol Pharmacol. 1987 Jun;65(6):1225-7.

PMID:
3621070

Supplemental Content

Support Center